2026-02-26 - Daily Actions

Market Brief Ticker Tape
1 min read

2026-02-26 - Daily Actions

10 tickers referenced · published Feb 26, 2026

Article published Feb 26, 2026. Prices below use latest available snapshots.

ADBE $254.04 +7.1% 30d AFRM $74.52 -2.0% 30d AMD $506.00 +2.1% 30d AMZN $261.31 +5.7% 30d ARKX $34.70 +14.5% 30d ARM $271.43 +1.6% 30d ASAN $8.83 +14.8% 30d AVGO $392.43 +5.8% 30d BE $232.16 +8.0% 30d CEG $278.20 +10.2% 30d

MARKET CONTEXT: VOO $632.48 (+0.7% 7D, -0.7% 30D, RSI 58 — at SMA, stable) | QQQM $250.15 (-0.4% vs SMA, RSI 57) | VIXY $27.25 (RSI 45 — fear cooling from 62) | GLD $476.01 (RSI 64, +3.2% above SMA — breakout continues)

Market stabilizing. VIXY RSI 45 (down from 62 on 02-22) = fear subsiding. 18 entry zones active (5 extreme, 8 oversold, 5 approaching). ASAN sole GOLDEN signal (RSI 19 + $8.3M insider buying). WDAY RSI 29 is the last SaaS laggard. ISRG RSI 9 + insider selling = do NOT buy. SaaS bounce closed most Feb-22 entries (CRM 27->57, NOW 24->57). Data center power overbought (CEG RSI 82, EQIX RSI 87).

Entry Zones (IN ZONE NOW)

EXTREME OVERSOLD (RSI < 20) - Capitulation Territory

Stock Current Zone RSI 30D Chg Source Action Notes
ISRG $476.32 <$480 9 -19.7% biotech-scan, bargain-bin 🔍 Research RETURNING. Surgical robotics monopoly. RSI 9 for 2nd scan. BUT insider selling -$282M at extreme low. Do NOT buy until insider selling stops. Data stale 02/05.
HIMS $15.23 <$16 9 -49.7% holdings, insider-scan 🔍 Research RETURNING. RSI 9 extreme. -50% 30D. Insider selling -$186.5M. Falling knife, not dip. Fresh data 02/26.
LEGN $17.20 Avoid 8 -27.1% biotech-scan ❌ Don't Buy RETURNING. RSI <10 for 3rd consecutive scan. No reversal signal. Thesis broken. Data stale 02/09.
U $28.81 Avoid 15 -37.2% insider-scan, holdings ❌ Don't Buy RETURNING. -37% 30D, insiders selling -$282M into freefall. Data stale 02/02.
ORCL $152.95 $148-158 15 -20.4% ai-scan, bargain-bin ✅ Strong Buy RETURNING. Oracle Cloud hyper-scaling. Database monopoly. -16% vs SMA. Data stale 02/03 — verify before acting.
IQV $162.31 $155-165 17 -32.2% biotech-scan 🔍 Research NEW. IQVIA CRO/analytics leader. -32% 30D, -17% vs SMA. Pharma R&D spending cuts? Need thesis check.
SOFI $22.08 Avoid 17 -24.6% insider-scan, holdings ❌ Don't Buy RETURNING. Insiders selling -$651M at capitulation. Data stale 02/02.
NFLX $80.78 <$85 19 -11.7% bargain-bin, holdings ⚠️ Caution RETURNING. 300M+ subs. Ad tier growth. BUT insiders selling -$1.3B at RSI 19. Data stale 02/03.
ASAN $9.91 $9-10 19 -23.1% insider-scan, holdings 🏆 Golden Signal RETURNING. RSI 19 + $8.3M insider BUYING = sole golden signal in universe. 3rd consecutive scan. Data stale 02/02.

OVERSOLD (RSI 20-30) - Strong Entry Zone

Stock Current Zone RSI 30D Chg Source Action Notes
PINS $22.00 $20-23 20 -17.0% insider-scan, holdings 🔍 Watch RETURNING. Social media pressure. Insider selling -$116M. Data stale 02/02.
ZS $169.39 <$172 23 -23.7% bargain-bin, cloud-etfs ⚠️ Caution RETURNING. Zero-trust cloud. Insiders selling -$174M into dip. Data stale 02/05. DCA only.
AFRM $61.99 $58-64 24 -23.3% insider-scan, holdings 🔍 Watch RETURNING. BNPL leader. Insiders selling -$327M. Data stale 02/02.
SAP $196.98 <$202 25 -18.1% bargain-bin 📈 Accumulate RETURNING. Global ERP king. 400K customers. Cloud migration. No insider exit flags. Data stale 02/03.
OKTA $81.64 $79-84 28 -6.9% bargain-bin 🔍 Watch RETURNING. Identity management. Breach recovery. Needs catalyst. Data stale 02/03.
GOOGL $306.33 $300-310 29 -8.1% ai-scan, bargain-bin, holdings 📈 Accumulate RETURNING. Search/cloud monopoly. Re-entered oversold (was RSI 32 on 02/22, now 29). BUT insider selling -$294M. Fresh data 02/26.
UNH $293.19 <$298 29 -12.5% bargain-bin 🔍 Watch RETURNING. Largest US health insurer. Regulatory/political risk elevated. Data 02/13.
WDAY $138.57 $134-142 29 -27.4% cloud-etfs, bargain-bin, candidates ✅ Strong Buy RETURNING. Last SaaS laggard still oversold. Enterprise HR lock-in. -27% 30D while CRM recovered to RSI 57. Fresh data 02/26.

APPROACHING OVERSOLD (RSI 30-40) - Watch Closely

Stock Current Zone RSI 30D Chg Source Action Notes
ADBE $269.39 $263-272 30 -19.8% bargain-bin, cloud-saas 📈 Accumulate RETURNING. Creative cloud monopoly. Firefly AI. -10.2% vs SMA. Data stale 02/05. Right at 30 threshold.
GIS $44.85 $43-46 30 +0.5% defensive-scan, consumer-staples 📈 Accumulate NEW. Only staple NOT in overbought rotation. -3.6% vs SMA. Contrarian setup. Fresh data 02/26.
PANW $166.95 $162-170 33 -12.6% bargain-bin 🔍 Watch RETURNING. Zero-trust leader. Insiders selling -$1.8B tempers conviction. Data 02/13.
AMZN $206.73 $200-212 34 -13.3% ai-scan, bargain-bin, holdings 📈 Accumulate RETURNING. AWS + e-commerce monopoly. RSI improved 25->34. CAVEAT: Bezos -$10.9B selling. Fresh data 02/26.
INTU $389.33 $378-395 35 -30.7% cloud-etfs, bargain-bin 📈 Accumulate RETURNING. Bounced from RSI 18 extreme. TurboTax monopoly. Tax season tailwind. Fresh data 02/26.
TMO $515.03 $505-520 32 -17.8% bargain-bin, holdings 📈 Accumulate RETURNING. Life sciences monopoly. Recovered from RSI 19. GLP-1 tailwind. Insider selling -$320M. Fresh data 02/26.
FSLR $201.52 $190-208 35 -17.1% energy 📈 Accumulate NEW. Domestic solar leader. -11.8% vs SMA. IRA/tariff protected. Fresh data 02/26.
LOW $264.70 $258-268 41 -4.8% retail-scan 🔍 Watch NEW. Home improvement leader. RSI dropped from 66 to 41 in 4 days. -4.3% vs SMA. Fresh data 02/26.
MDT $98.61 $94-97 36 -2.0% biotech-scan 🔍 Watch NEW. Medical devices. RSI approaching oversold. Data 02/23.

Price Alerts (Waiting for Entry)

Stock Alert Entry Zone Source Set Date Status
AMD $185-195, RSI <48 -19% 30D laggard, thesis intact nvda-ecosystem 2026-02-22 ⏳ Waiting — RSI 57, above zone
TSLA $380-415, RSI <30 Insider buying +$200.6M insider-scan 2026-02-22 ⏳ Waiting — RSI 56
ARM $110-115, RSI <55 Wait for full reset from RSI 71 nvda-ecosystem 2026-02-16 ⏳ Waiting — RSI 71, still extended
TSM $345-358, RSI <60 SMA retest after +12% run nvda-ecosystem 2026-02-16 ⏳ Waiting — RSI 71, still extended
NVDA $181-186, RSI <55 SMA retest, core AI position nvda-ecosystem 2026-02-22 ⏳ Watching — RSI 63, above zone
AVGO $295-305, RSI <45 Custom silicon pullback nvda-ecosystem 2026-02-26 ⏳ Waiting — RSI 51, watch for deeper dip
CEG $265-285, RSI reset to 55 Nuclear AI power thesis energy, ai-infra 2026-02-26 ⏳ Waiting — RSI 82, overbought now
GEV $750-800, RSI reset to 60 Grid infrastructure energy, ai-infra 2026-02-26 ⏳ Waiting — RSI 77, extended
CSCO $72-76, RSI <45 Post-earnings contrarian ai-infra 2026-02-26 ⏳ Watching — RSI 50, not yet oversold
SCHD/VYM After RSI reset <60 Dividend ETFs at RSI 87-90 etf-universe 2026-02-26 ⏳ Waiting — extreme overbought, do NOT chase

Exit Alerts (Holdings)

Stock Alert Type Entry Current P&L Set Date Status
BE $140 Stop-loss (-15%) $164.96 $163.68 -0.8% 2026-02-03 🟡 Near entry, above stop — recovered from 02/22 scare
WMT $109 Stop-loss (-15%) $128.08 $124.73 -2.6% 2026-02-03 🟡 Below entry, well above stop
NET $151 Stop-loss (-15%) $178.30 avg $173.33 -2.8% 2026-01-26 🟡 Below entry — -10% 7D pullback, monitor closely
DOCN Watch Sudden crash — $53.82 +14% est 2026-02-26 🚨 NEW — -21% 7D crash. Was compounder, now falling. Check earnings/catalyst.
MRNA RSI 87 Sell into strength — $51.72 +24% 7D — 🚨 Trim — RSI 87 extreme overbought. Swan watch position.
PHGE RSI 77 Sell into strength — $6.23 +176% 30D — 🚨 Sell — Parabolic. RSI 77. Stale data 02/02.
NTLA RSI 73 Watch for fade — $13.67 — — ⚠️ Watch — Surging without clear catalyst. Biotech fades fast.
BTC ETF $34 Stop-loss (-15%) $40.05 — — 2026-02-03 ⏳ Active — need price check
ARKX $28 Stop-loss (-15%) $32.40 — — 2026-02-03 ⏳ Active — need price check

Sector Rotation Signals

Signal Trigger What It Means Status
Gold breakout accelerating GLD RSI 64, +6.2% 7D, +3.2% above SMA Safe-haven bid still strong. Institutions buying safety alongside equity bounce. 🟢 ACTIVE — Hold GLD
VIXY cooling RSI 45 (was 62 on 02/22) Fear subsiding from Feb highs. Closer to all-clear. 🟢 Improving — Watch for RSI <40
Dividend ETFs extreme overbought SCHD RSI 90, VYM RSI 87 Institutions hiding in dividends. Defensive rotation overdone. Do NOT chase. 🔴 Danger — Trim/avoid SCHD/VYM
SaaS bounce from capitulation CRM RSI 27->57, NOW RSI 24->57 in 4 days Most SaaS entry window closed. WDAY (RSI 29) last opportunity. 🟡 Window closing
Data center power overbought CEG RSI 82, EQIX RSI 87, GEV RSI 77 Nuclear/power theme priced in. Pullback risk elevated. 🔴 Overbought — Don't chase
Cloud ETFs bounced to neutral WCLD RSI 53, IGV RSI 54 (was 32-33) Relief rally, not confirmed recovery. Need SMA reclaim. 🟡 Watch for SMA reclaim
GDX lagging GLD GLD +6.2% 7D vs GDX -15.4% 7D Unusual divergence — gold miners NOT confirming gold rally. 🟡 Watch — GDX catch-up or GLD reversal?
Home improvement weakening LOW RSI 66->41 in 4 days Housing data weakness hitting HD/LOW. Potential entry forming. 🟡 Emerging entry

Insider Activity Summary

Signal Stocks Implication
🏆 GOLDEN ASAN (RSI 19 + $8.3M buying) Sole golden signal for 3rd consecutive scan. Multiple insiders buying at capitulation. Highest conviction entry.
🟢 BUYING TSLA (+$200.6M, RSI 56), CRSP (+$26.6M, RSI 81) TSLA at neutral RSI — not oversold; CRSP buying at overbought = insiders confident in gene editing thesis
🔴 EXTREME SELL INTO DIP ISRG (-$282M, RSI 9), HIMS (-$187M, RSI 9), U (-$282M, RSI 15), SOFI (-$651M, RSI 17) Insiders abandoning during extreme capitulation. These are NOT buy signals despite low RSI.
⚠️ SELLING INTO DIP NFLX (-$1.3B, RSI 19), AFRM (-$327M, RSI 24), GOOGL (-$294M, RSI 29), ZS (-$174M, RSI 23), PINS (-$116M, RSI 20) Smart money exiting oversold positions. Tempers buy conviction.
🔍 HEAVY SELLING AT NEUTRAL AMZN (-$10.9B, Bezos estate), PLTR (-$3.4B), NVDA (-$3B), LLY (-$4.8B), PANW (-$1.8B), SNOW (-$1.2B) Institutional distribution at fair-value levels. Routine for most.

Pending Research Actions

Action Source Priority Status
Execute ASAN position (RSI 19, $8.3M insider buying, 3rd scan golden signal) insider-scan, holdings CRITICAL 🔍 Todo
Execute WDAY entry (RSI 29, last SaaS laggard, -27% 30D, enterprise HR moat) cloud-etfs, bargain-bin HIGH 🔍 Todo
Research DOCN -21% crash (was compounder, sudden drop — earnings or structural?) holdings HIGH 🔍 Todo
Trim MRNA (RSI 87, extreme overbought — take profit on swan watch position) holdings, biotech HIGH 🔍 Todo
Trim/Sell PHGE (RSI 77, +176% 30D parabolic — sell into strength) holdings HIGH 🔍 Todo
Research IQV entry (RSI 17, NEW — CRO leader -32% 30D, need thesis check) biotech-scan HIGH 🔍 Todo
Decide U position (RSI 15, -37% 30D, insiders selling — cut or hold?) holdings HIGH 🔍 Todo — carry forward
Review HIMS (RSI 9, -50% 30D, insiders selling — exit or speculative hold?) holdings HIGH 🔍 Todo — carry forward
ADBE entry evaluation (RSI 30, -20% 30D, creative cloud monopoly) bargain-bin, cloud-saas MEDIUM 🔍 Todo
GOOGL DCA decision (RSI 29, re-entered oversold, but -$294M insider selling) ai-scan, holdings MEDIUM 🔍 Todo
Research FSLR (RSI 35, -17% 30D — solar policy risk vs tariff protection) energy MEDIUM 🔍 Todo
INTU accumulation (RSI 35, -31% 30D, tax season structural tailwind) cloud-etfs MEDIUM 🔍 Todo
Monitor NET stop-loss ($151 stop, currently $173 — -10% 7D pullback concerning) holdings MEDIUM ⏳ Watching
Monitor VIXY (RSI 45, cooling — all-clear at RSI <40) etf-universe MEDIUM ⏳ Watching
Research NVO collapse (-22.7% 7D, -41.5% 30D — GLP-1 thesis cracking?) biotech-scan LOW 🔍 Todo
Fetch missing data (DXCM, RGEN, DG, DLTR, FIVE, AMAT) various scans LOW 🔍 Todo
Research GIS contrarian (RSI 30, only staple not in overbought rotation) defensive-scan LOW 🔍 Todo

The Gold

Key Discoveries

Discovery Implication
VIXY RSI 45 (was 62 on 02-22) — fear subsiding Market risk appetite improving. Closer to all-clear for adding risk. But not there yet — wait for RSI <40.
SaaS bounce closed most Feb-22 entries in 4 days CRM 27->57, NOW 24->57, META 26->44 — the oversold window was brief. WDAY (RSI 29) is the last one open. Act now or miss it.
ASAN golden signal for 3rd consecutive scan Persistence of insider buying at capitulation = floor forming. Highest conviction entry in the universe.
DOCN -21% 7D surprise crash Was a compounder (+14% gain), now at risk. Need to identify catalyst before deciding hold/sell.
ISRG RSI 9 + insider selling -$282M Despite monopoly quality, insiders are exiting at all-time RSI extreme. Do NOT buy until insider selling stops.
NVO -22.7% 7D, -41.5% 30D GLP-1 competitive disruption is real and accelerating. Biggest single-stock collapse in scan universe. Avoid.
IQV RSI 17, -32% 30D — new extreme entry candidate CRO/health analytics leader in capitulation. Need to understand if pharma R&D cuts are cyclical or structural.
SCHD RSI 90, VYM RSI 87 Dividend ETFs in extreme overbought = institutions still hiding in safety. When this unwinds, growth names re-rate.
GEV +29.6% 30D at RSI 77 Data center power demand is the biggest infrastructure trade of this cycle — but you've missed the entry. Wait for reset.
WDAY RSI 29 while CRM recovered to RSI 57 WDAY is the only cloud name that did NOT participate in the SaaS bounce. Either structural issue or last bargain.

Mistakes (Don't Repeat)

Mistake Lesson
Hesitating on CRM at RSI 27 (02-22) CRM went 27->57 in 4 days. RSI <30 in quality names = act fast, windows close violently.
No DOCN stop-loss on a compounder Even winners need stop-losses. DOCN -21% 7D proves it. Set stops on ALL positions.
Treating ISRG RSI 9 as buy signal without checking insiders Low RSI alone is NOT a buy signal. Always cross-check insider data. -$282M selling = insiders see more pain.
Missing LOW RSI 66->41 collapse in 4 days Fast RSI drops in quality names = opportunity forming. Need daily monitoring not weekly.

Open Questions

  • WDAY RSI 29 while CRM bounced to 57 — is WDAY a structural loser or the best remaining SaaS entry?
  • ASAN golden signal 3rd scan — when does thesis convert to position? What is the specific catalyst?
  • DOCN -21% 7D — earnings miss, guidance cut, or competitive pressure?
  • IQV -32% 30D — is pharma R&D spending cut cyclical (buy) or AI-structural (avoid)?
  • NVO -41.5% 30D — is this GLP-1 competitive disruption permanent or an overreaction?
  • VIXY RSI 45 — will it break below 40 for clean all-clear, or does macro headwind persist?
  • SCHD/VYM RSI 87-90 — when does defensive rotation reverse back to growth?

Sources: 13 sector scans, 1 holdings file, 11 candidate files, 1 portfolio snapshot. Validated via OHLC data 2026-02-26. Previous actions: 2026-02-22-actions.md.

Sources

  • Tape data (price/RSI/trend figures): desk pre-computed watchlist summaries as of the artifact date — *.